Who owns Arbutus Biopharma?
- Ticker: ABUS
- CUSIP Number: 03879j100
Top investors of Arbutus Biopharma stock
Who bought or sold Arbutus Biopharma this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | ||
---|---|---|---|---|---|---|
Rtw Investments | 6.0M | $19M | -13% | Sep 2020 | ||
Foresite Capital Management IV | 3.3M | $10M | 100% | Sep 2020 | ||
Morgan Stanley | 2.9M | $9.1M | -13% | Sep 2020 | ||
Vanguard Group | 2.2M | $7.0M | 23% | Sep 2020 | ||
Think Investments | 2.0M | $6.3M | 100% | Sep 2020 | ||
Advisor Group Holdings | 1.4M | $4.3M | 100% | Sep 2020 | ||
BlackRock | 1.0M | $3.3M | 100% | Sep 2020 | ||
Hudson Bay Capital Management | 710k | $2.2M | -27% | Sep 2020 | ||
Susquehanna International | 659k | $2.1M | 2368% | Sep 2020 | ||
Ameriprise Financial | 656k | $2.1M | 100% | Sep 2020 | ||
Cowen And Company | 523k | $1.6M | -88% | Sep 2020 | ||
Setup an alertWant to be notified whenever an investor makes a significant change to their holdings of Arbutus Biopharma? |
||||||
PRIMECAP Management Company | 500k | $1.6M | 0% | Sep 2020 | ||
Bank Of Montreal | 406k | $1.2M | -13% | Sep 2020 | ||
Geode Capital Management | 380k | $1.2M | 22% | Sep 2020 | ||
Goldman Sachs Group | 254k | $795k | -85% | Sep 2020 | ||
DekaBank Deutsche Girozentrale | 250k | $766k | 100% | Sep 2020 | ||
Citadel Advisors | 240k | $0 | -83% | Sep 2020 | ||
Deutsche Bank Aktiengesellschaft | 128k | $400k | 100% | Sep 2020 | ||
CalPERS | 125k | $392k | 100% | Sep 2020 | ||
Northern Trust | 120k | $384k | 16% | Sep 2020 | ||
Ikarian Capital | 115k | $360k | 100% | Sep 2020 | ||
LMR Partners | 108k | $338k | 0% | Sep 2020 | ||
Springbok Capital Management | 90k | $282k | 100% | Sep 2020 | ||
Group One Trading | 74k | $230k | 100% | Sep 2020 | ||
SG3 Management | 56k | $173k | 100% | Sep 2020 | ||
Mirabella Financial Services | 53k | $166k | 100% | Sep 2020 | ||
State Street Corporation | 52k | $162k | 100% | Sep 2020 | ||
Heather K. Mellem | 51k | $159k | 100% | Sep 2020 | ||
Etf Managers | 45k | $144k | 121% | Sep 2020 | ||
Assenagon Asset Management | 44k | $139k | 100% | Sep 2020 | ||
Bogle Investment Management | 42k | $131k | 100% | Sep 2020 | ||
Qube Research & Technologies | 41k | $129k | -30% | Sep 2020 | ||
Mackenzie Financial | 40k | $125k | 0% | Sep 2020 | ||
Charles Schwab Investment Management | 33k | $104k | 100% | Sep 2020 | ||
Engineers Gate Manager | 30k | $93k | 100% | Sep 2020 | ||
CSS | 27k | $84k | 100% | Sep 2020 | ||
Two Sigma Advisers | 24k | $75k | -86% | Sep 2020 | ||
Bayesian Capital Management | 21k | $64k | 100% | Sep 2020 | ||
Bank of New York Mellon | 18k | $56k | 100% | Sep 2020 | ||
Citigroup | 18k | $56k | 297% | Sep 2020 | ||
Jane Street | 17k | $53k | -84% | Sep 2020 | ||
HAP Trading | 14k | $8.0k | 100% | Sep 2020 | ||
Royal Bank of Canada | 14k | $38k | 68% | Sep 2020 | ||
Boothbay Fund Management | 13k | $41k | 100% | Sep 2020 | ||
ExodusPoint Capital Management | 13k | $41k | -24% | Sep 2020 | ||
Scotia Capital | 12k | $37k | 1% | Sep 2020 | ||
Secure Asset Management | 10k | $31k | 0% | Sep 2020 | ||
IHT Wealth Management | 10k | $31k | 100% | Sep 2020 | ||
Valeo Financial Advisors | 8.0k | $25k | 100% | Sep 2020 | ||
UBS Group | 7.0k | $28k | -98% | Sep 2020 | ||
Wells Fargo & Company | 5.3k | $15k | 84% | Sep 2020 | ||
Cutler | 5.2k | $18k | -77% | Dec 2020 | ||
Tower Research Capital | 4.4k | $14k | -61% | Sep 2020 | ||
Sterling Investment Advisors | 4.0k | $14k | 0% | Dec 2020 | ||
Bank of America Corporation | 3.0k | $0 | -95% | Sep 2020 | ||
Bank Julius Baer & Co. Ltd, Zurich | 1.5k | $5.0k | 100% | Sep 2020 | ||
Sowell Financial Services | 925.00 | $3.0k | 100% | Dec 2020 | ||
Larson Financial Group | 901.00 | $3.0k | 100% | Dec 2020 | ||
Parallel Advisors | 550.00 | $2.0k | 100% | Sep 2020 | ||
Harbor Investment Advisory | 500.00 | $2.0k | -50% | Sep 2020 | ||
Coastal Capital Group | 300.00 | $999.990000 | 0% | Sep 2020 | ||
AdvisorNet Financial | 272.00 | $1.0k | 100% | Sep 2020 | ||
Flagship Harbor Advisors | 200.00 | $0 | 0% | Sep 2020 | ||
NEXT Financial | 200.00 | $1.0k | 100% | Sep 2020 | ||
Massey, Quick & Co | 100.00 | $0 | 0% | Sep 2020 |
Who sold out of Arbutus Biopharma?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Jennison Associates | Jun 2020 | 340k | $618k |
Squarepoint Ops | Jun 2020 | 322k | $586k |
Two Sigma Investments | Jun 2020 | 284k | $516k |
Millennium Management | Jun 2020 | 223k | $405k |
Arrowstreet Capital, Limited Partnership | Jun 2020 | 62k | $113k |
Renaissance Technologies | Jun 2020 | 61k | $111k |
Russell Investments | Jun 2020 | 43k | $78k |
Creative Planning | Jun 2020 | 33k | $60k |
Virtu Financial | Jun 2020 | 17k | $31k |
A.R.T. Advisors | Jun 2020 | 14k | $26k |
Cubist Systematic Strategies | Jun 2020 | 13k | $23k |
Wedbush Morgan Securities | Jun 2020 | 11k | $20k |
CNB Bank | Jun 2020 | 1.0k | $2.0k |